In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Meet Merck’s Dealmaker: A Conversation With Roger Pomerantz

Executive Summary

Merck’s new head of worldwide licensing and knowledge management Roger Pomerantz, MD, talks with IN VIVO about Merck’s business development strategy, whether biotech passion can exist on a Big Pharma scale, and the art of the deal.


Related Content

Pharma Deals That Generate Lasting Value: A Roundtable Discussion
How Far Can Big Pharma Collaboration Go? Much Further, Executives Say
Merck CEO To Street: Watch For Short-term Adaptability, Long-Term Innovation
Merck's Capital Idea: Industry's Latest Push to Strengthen VC Ties
Merck Plans To Shed 13% Of Work Force By 2015
Intracranial Hemorrhage The Culprit In Merck's Vorapaxar Trial
At Merck, Business Development As Usual?


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts